Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-01
2009-06-23
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S146000, C548S190000, C548S193000, C548S194000, C548S195000, C514S365000, C514S370000
Reexamination Certificate
active
07550493
ABSTRACT:
A halogenated benzamide derivative characterized by greater specificity for viral pathogens and less disruptive to beneficial gut microflora, according to formula (III): in which R1is a halogen atom, and R2-R6are independently hydrogen, hydroxyl, C1-C4alkyl, —C1-C4alkoxy, acyloxy, nitro, halogen, —C(O)R7where R7is —C1-C4alkyl, or, aromatic including salts and hydrates of these compounds and where at least two of R2-R6are not hydrogen and where at least one of R2-R6are hydroxy or acyloxy.
REFERENCES:
patent: 3736330 (1973-05-01), Haken et al.
patent: 3950351 (1976-04-01), Rossignol et al.
patent: 5387598 (1995-02-01), Rossignol
patent: 5578621 (1996-11-01), Rossignol
patent: 5856348 (1999-01-01), Rossignol
patent: 5859038 (1999-01-01), Rossignol
patent: 5886013 (1999-03-01), Rossignol
patent: 5935591 (1999-08-01), Rossignol
patent: 5965590 (1999-10-01), Rossignol
patent: 5968961 (1999-10-01), Rossignol
patent: 6020353 (2000-02-01), Rossignol
patent: 6117894 (2000-09-01), Rossignol
patent: 6737382 (2004-05-01), Iwataki et al.
patent: 7037929 (2006-05-01), Pevarello et al.
patent: 7285567 (2007-10-01), Rossignol
patent: 2004/0259877 (2004-12-01), Muto et al.
patent: 1 276 663 (1972-06-01), None
Esposito et al. “In Vitro Efficacies of Nitazoxanide and Other Thiazolides againstNeospora caninumTachyzoltes Reveal Antiparasitic Activity Independent of the Nitro Group,” 2005, Antimicrobial Agents and Chemotherapy, 49(9):3715-3723.
Husain et al. “Search for Patent Anthemintics—Part XIII 2-(3,5-Substituted Salicylamido/Cinnamido)-4,5-Substituted Thiazoles,” 1979, Journal of Indian Chemical Society, vol. LVI, pp. 917-918.
Pevarello et al., 2000-STN International HCAPLUS Database, Columbus, Ohio Accession No. 2000:314687.
Amemiya et al., 2001-STN International HCAPLUS Database, Columbus, Ohio Accession No. 2001:816614.
Korba, Brent E., et al. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitus C virus replication; Science Direct, Antiviral Research 77, Aug. 10, 2007; pp. 56-63.
Novak Druce & Quigg
Romark Laboratories, LC
Shameem Golam M
LandOfFree
Halogenated benzamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogenated benzamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogenated benzamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108006